ResearcherUniversity of BernActive in the last 2 years
Sarah Peisl
Matched on ORCID iD 0000-0002-1215-6964; OpenAlex author ID A5040795483. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features: Protocol for a Retrospective Cross-Sect… Co-author DOI 10.2196/76811↗
- Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature. Co-author DOI 10.1371/journal.pone.0252397↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Claudia Mellenthin · 2 shared papers, 2021–2025 · strength 0.40
- Paper IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features:… DOI 10.2196/76811↗
- Paper Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical l… DOI 10.1371/journal.pone.0252397↗
- Léo Bühler · 2 shared papers, 2021–2025 · strength 0.40
- Paper IL-6/GP130/JAK/STAT3 Pathway Activation in Pancreatic Ductal Adenocarcinoma and Its Association With Clinical Features:… DOI 10.2196/76811↗
- Paper Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical l… DOI 10.1371/journal.pone.0252397↗
- Cornelia Schneider · 1 shared paper, 2025 · strength 0.25
- Iréne Esposito · 1 shared paper, 2025 · strength 0.25
- Bernhard Egger · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.